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We thank the Editors for the opportunity to publish our article with discussion and we are 
grateful to the discussants. The diverse perspectives provided by the discussants are indeed 
valuable and contain many potential directions for further research. We hope that our work 
presented will generate further innovations in modeling time-varying effects in the context 
of profiling models.
Insightful comments were provided by professors Kalbfleisch and He (hereafter referred to 
as KH). Indeed, our proposed fixed effects (FE) model for time dependent assessment of 
dialysis facilities was inspired by the works of KH and colleagues (He et al. 2013, 
Kalbfleisch and Wolfe 2013) and also based on our own simulation studies which supported 
many of the advantages of FE models over random effects (RE) models reported by KH 
(Chen et al. 2017), especially in the dialysis population where patients are admitted to the 
hospital twice each year on average and where baseline 30-day (unplanned) readmission is 
not rare (about 30%, USRDS 2012). Professor Normand and colleagues (hereafter referred 
to as HZN) have been in the forefront of the development of methods for assessing the 
quality of health care providers for over 20 years and have contributed to the methodology 
adopted by the Centers for Medicare and Medicaid Services (CMS). We appreciate the 
background provided by HZN and the discussion of the policy-related aspects. Finally, we 
thank professor Goetghebeur for a stimulating discussion of our paper from a causal 
inference perspective. As many of the points brought up by the discussants were related, we 
try to touch upon the main points below grouped by related themes.
1 Mortality as a Competing Risk
The discussants raised good points regarding the interpretations of the proposed time-
varying metric, SDRR(t), without information on mortality. Mortality is indeed a 
complicating issue. We note that the literature on standard (annual) profiling assesses 
readmission and mortality in separate models. Similarly, we developed SDRR(t) for 
assessing the readmission rate in a partly conditional model, conditional on being alive, 
which we believe is a useful first step. However, interpretations on overall facility 
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performance would be most meaningful if combined with facility profiling results based on 
mortality. As mentioned in the Discussion section of our article, an alternative approach is to 
jointly model mortality/survival and hospital readmissions, which we are currently 
investigating.
A related point was raised by professor Goetghebeur on the exclusion of hospitalizations 
which end in death, inherent also in standard profiling through SRR. The reason for 
excluding index hospitalizations that result in death within 30 days is because there would 
be no chance for a readmission, and also 30-day mortality is treated as a separate outcome. 
This relates again to our discussion above on the traditional practice of developing separate 
profiling models based on mortality and other adverse patient outcomes.
2 Comparison of Facility Performance
The discussants brought up issues on comparison of facility performance, within the context 
of direct and indirect standardization. The discussants also pointed out that regression 
models may be overreaching or extrapolating when facility effects are applied outside of the 
case-mix of a particular facility with direct standardization. We agree with this view and 
focused exclusively on SDRR(t) with indirect standardization in our paper which provides a 
measure for each facility relative to a reference (e.g., national norm) for patients actually 
treated at the given facility. We also note that it may be an overreach for the proposed model 
when facility effects are applied to other facilities with a different mortality profile. Hence, 
we believe the direct standardization version of SDRR(t) suggested by KH would be 
meaningful for comparisons between facilities not only with similar case-mix but also with 
similar mortality profiles.
3 Issues Related to the Outcome Considered
A fair amount of the discussion was on issues related to the modeled outcome of hospital 
readmissions and comparisons and contrasts with modeling similar outcomes such as 
general hospitalizations. We would like to start by noting that the proposed methodology 
would apply readily also to modeling general hospitalizations. As correctly pointed out by 
KH, the outcome/modeling considered of hospital readmission conditions on the existence 
of an index hospitalization. Hence we agree with professor Goetghebeur that facility effect 
estimates would be more influenced by patients with higher rates of hospitalizations in 
general since they contribute more data points (index hospitalizations) for estimation. We 
view this as a consequence of the definition of the outcome considered. Note that this 
consideration does not apply to modeling general hospitalization counts, where the outcome 
is no longer conditional, but either refers to the actual count of hospitalization discharges or 
a binary indicator of the existence of hospitalization discharges in discrete time intervals. We 
appreciate KH for pointing out the work of Liu and colleagues (2012), on modeling the 
sequence of hospitalizations by a counting process Nij(t). Our partly conditional model, 
conditional on being alive, is similar to the approach in Liu et al. (2012), which is a partial 
marginal model.
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4 Adjustment for Covariates at Initiation of Dialysis
Also related to the particular outcome considered − hospital readmissions − the discussants 
touched upon an important limitation in the proposed modeling. In order not to adjust for 
time-varying covariates that may explain away facility effects, the model only adjusts for 
covariates prior to dialysis. This is not the case for the standard formulation of SRR, where 
each index hospitalization is treated as a separate case and hence the modeling can adjust for 
case-mix at the time of the index hospitalization. As HZN points out, adjustment for case-
mix from initiation of dialysis would work better for index hospitalizations close to initiation 
of dialysis, but residual confounding can build for index hospitalizations far away from 
initiation of dialysis. This point can be considered in determining the total follow-up time 
after initiation of dialysis for TDP. However, this consideration needs to be balanced by the 
fact that too short of a follow-up may lead to unstable results in smoothing based estimation 
procedures. Note again that, as pointed out by KH, adjustments for case-mix from initiation 
of dialysis may be more plausible for the outcome of general hospitalizations.
5 Choice of Time Scale and Connections to Policy
KH discussed the choice of calendar time as an alternative time scale (instead of time from 
initiation of dialysis). This choice depends on the main objective of the profiling analysis 
(discussed more below). We agree with KH that when the main interest is in detecting 
quality problems by regulatory agencies and tied to annual payment, the choice of a 
chronological time scale and a prevalent cohort are natural. Our proposed model would 
indeed be applicable to this alternative time scale. As noted by KH, “one could also entertain 
models which allow both time scales by adjusting for specific parametric functions of 
chronological time in the model (M1).” We alluded to this in the Discussion section of our 
article and we have recently developed a more general varying-coefficient model (for 
multilevel risk factors) that can accommodate both time scales by adjusting for a 
nonparametric function of chronological time (Li et al. 2017).
With respect to the more general policy discussions provided by HZN, we first note that the 
results of profiling modeling are utilized for multiple objectives, including: (1) identifying 
providers with below standard performance by government agencies (e.g., CMS) for 
regulatory or payment purposes, (2) conveying information to patients regarding the quality 
of care, and (3) informing potential areas for improvement with respect to patient treatment 
strategies and processes of care among others. Policy questions typically fall under category 
(1) and desired characteristics of a quality measure that appeal to stakeholders are even more 
complicated for patients with end-stage renal disease (ESRD) because of the complexity of 
care for dialysis patients and the critical need for coordination of care between hospital and 
dialysis facility care teams. In the discussion, HZN stated: “we find it difficult to attribute 
responsibility of post-discharge care following a hospitalization to the dialysis center rather 
than to the hospital where the hospitalization took place … “. Although this concern is 
understandable, there are competing policy objectives that are unique to dialysis patients. To 
put this into context, a large proportion of dialysis patient readmissions occur within the first 
week after index discharge (CMS 2014), but there is no standard of discharge coordination 
between hospitals and dialysis facilities. Indeed, the dialysis facility patient-care staff may 
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not see patients post discharge until the next dialysis session which could be several days 
later. Therefore, close coordination of care between hospitals and dialysis facilities is 
needed. Also, key clinical parameters (e.g., anemia, serum albumin, and mineral metabolism 
and bone disease) as well as dry weights may have substantially changed over the course of 
hospitalization, and in prior studies of dialysis patients clinical parameters were found to be 
significantly changed after hospitalization (Chan et al. 2009). Therefore, care coordination 
and discharge planning are paramount to early identification and intervention for recurrent 
illness immediately following discharge. The policy rationale for assessing 30-day hospital 
readmission among dialysis facilities is to affect care processes, and, specifically to 
encourage close coordination of care between discharging hospitals and dialysis facilities 
(CMS 2014), which currently there is no standard. See also Wish (2014) and discussion by 
KH, Section 2.
Although we avoided discussion of policy-related issues in our paper, we truly appreciate 
HZN for highlighting this important motivation to the discussion of our paper. We take this 
opportunity to also highlight objective (3) above. As pointed out in our paper, methods to 
monitor patient outcomes continuously over time are of particular relevance for patients on 
dialysis, since they require continuous medical care on maintenance dialysis and are at high 
risk for hospitalization. Being able to estimate the readmission (or hospitalization) risk 
trajectory for each facility over time from the start of dialysis, relative to a reference, is 
useful to flag facilities (as well as time periods) for further examination of care processes/
factors for improvement, independent of regulatory or payment reimbursement issues. 
Finally, implemented policies that involve health care reimbursement based on (feasible and 
simple) quality measures can result in anticipated outcomes as well as driving unanticipated 
consequences. For example, do short-term (annual) measures discourage exploration of 
innovations to achieve better patient outcomes over a longer period of time? Despite the 
limitations of our proposed method, we hope that it generates research that goes beyond 
annual (time-static) measures.
6 Causal Inference and Between Facility Variation
As noted in the above sections, the exclusion of hospitalizations where death occurs within 
30 days of index hospitalization and inclusion of hospital random effects to arrive at 
shrinkage (biased) estimates are both inherent in standard (annual) profiling, issues that 
Goetghebeur discussed in our time-varying setting. Furthermore, annual profiling models are 
typically based on administrative databases in practice that do not have many relevant 
patient-level factors (e.g., genetics) or facility-level factors unrelated to care that should be 
accounted for. Indeed, these issues, among others, pose problems when they are viewed 
through the lens of causal inference and they are further complicated in the time-varying 
effect setting as discussed by professor Goetghebeur. As KH pointed out succinctly, 
“Although widely used, the term facility effect is a poor one since it carries a connotation of 
causality that may not be true”. We also pointed out in the Discussion section of our paper, 
that efforts to further model additional relevant factors (patient and facility factors not 
related to care) to reduce total unexplained between-facility variation are important. KH 
suggested another interesting approach that seems to flexibly allow for one to specify a 
proportion of total between-facility variation as being attributable to the quality of care 
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(Kalbfleisch et al. 2017). Efforts to account for variation that are due to factors beyond the 
facility’s control (but still achieve the policy objectives, e.g. encouraging close coordination 
of care between dialysis facilities and discharging hospitals) will improve interpretation of 
‘facility effect’ measures and also contribute towards acceptance by stakeholders. We are 
thankful for the insightful discussion of KH on between-facility variation and the use of the 
empirical null. In particular, we look forward to the forthcoming work by professor 
Kalbfleisch et al. (2017) that specify a proportion of between-facility variation as due to 
quality of care.
7 Interaction Between Patient Factors and Health-Care Providers
Our work and others in 30-day hospital readmission have not considered interactions 
between patient factors and providers; the setting in which professor Goetghebeur and 
colleagues (Varewyck et al. 2016) examined these interactions focuses on the situation 
where some providers perform structurally better in certain subgroups of patients (e.g., some 
providers specializing in care for pediatrics vs. adult patients). Although this may be relevant 
in some contexts, we do not see this as pertinent in context of dialysis patient care.
References
Centers for Medicare & Medicaid Services (CMS)/UM-KECC. Report for the standardized 
readmission ratio, 2014 (updated 2017). https://www.cms.gov/Medicare/Quality-Initiatives-Patient-
Assessment-Instruments/ESRDQIP/Downloads/MeasureMethodolo-
gyReportfortheProposedSRRMeasure.pdf. Accessed February 20, 2018
Chan KE, Lazarus JM, Wingard RL, and Hakim RM (2009). Association between repeat 
hospitalization and early intervention in dialysis patients following hospital discharge. Kidney 
International 76, 331–341. [PubMed: 19516243] 
Chen Y, Şentürk D, Estes JP, Campos LF, Rhee CM, Dalrymple LS, Zhang L, Kalantar-Zadeh K, and 
Nguyen DV (2017). Performance characteristics of profiling methods and the impact of inadequate 
case-mix adjustment. Submitted.
He K, Kalbfleisch JD, Li Y, and Li Y (2013). Evaluating hospital readmission rates in dialysis 
facilities; adjusting for hospital effects. Lifetime Data Analysis 19, 490–512. [PubMed: 23709309] 
Kalbfleisch JD, He K, Xia L, and Li Y (2017). Does the inter-unit reliability (IUR) measure reliability? 
Submitted.
Kalbfleisch JD, and Wolfe RA (2013). On monitoring outcomes of medical providers. Statistics in 
Biosciences 5, 286–302.
Li Y, Nguyen DV, Chen Y, Rhee CM, Kalantar-Zadeh K, and Şentürk D (2017). Modeling time-
varying effects of multilevel risk factors of hospitalizations in patients on dialysis. Submitted.
Liu D, Schaubel DE, and Kalbfleisch JD (2012). Computationally efficient marginal models for 
clustered recurrent event data. Biometrics 68, 637–647. [PubMed: 21957989] 
Renal Data System U.S., USRDS 2012 Annual Data Report: Atlas of Chronic Kidney Disease and 
End-Stage Renal Disease in the United States, National Institutes of Health, National Institute of 
Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2012.
Varewyck M, Vansteelandt S, Eriksson M, and Goetghebeur E (2016). On the practice of ignoring 
center-patient interactions in evaluating hospital performance. Statistics in Medicine 35, 227–238. 
[PubMed: 26303843] 
Wish JB The role of 30-day readmission as a measure of quality (2014). Clinical Journal of the 
American Society of Nephrology 9, 440–441. [PubMed: 24509293] 
Estes et al. Page 5
Biometrics. Author manuscript; available in PMC 2019 February 04.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
